1Thurlimann B, Keshaviah A, Coates AS, et al. A comparison of letrozole and tamoxifen in post menopausal women with early breast cancer[J]. N Engl J Med, 2005, 353(26): 2747.
2Baum M, Budzar A U, Cuzick J, et al. Anastrozole alone or in combination with tarnoxifen versus tarnoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial [ J ]. Lancet, 2002, 359 (9324): 2131.
3Mansell J, Monypenny I J, Skene A I, et al. Abstracts of the 29th Annual San Anmio Breast Cancer Symposium[J ]. Breast Cancer Res Treat, 2006, 100(Suppl 1): 111.
4Heimann R, Hellan S. Clinical progression of breast cancer manignant behavior: What to expect and when to expect it [J]. J Clin Oncol, 2000, 18(3): 591.
5Ries L A G, Harkins D, Krapcho M, et al. SEER cancer Statistics Review [ R ]. 1975 - 2003, National Cancer Institute.
6Citron M L, Berry D A, Cirrincione C, et al. Randomized trial of dose-dense versus conventionally scheduled and saquential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 [J ]. J Clin Oncol, 2003:21 (8) : 1431.
7Coombes R C, Paridaens R, Jassem J, et al. First mature analysis of the Intergroup Exernestane Study[J]. J Clin Oncol, 2006, 24(Suppl 18): 933.
8Lamerato L, Havstad S, Gandhi S K, et al. Abstracts of the 27th Annual San Antonio Breast Cancer Symposium [ J ]. Breast Cancer Res Treat, 2004, 88(Suppl 1): 104.
9Delea T E, Berger A, Hagiwara M, et al. Abstracts of the 29th Annual San Anmio Breast Cancer Symposium [ J ]. Breast Cancer Res Treat, 2006, 100(Suppl 1): 230.
10Coates A S, Keshaviah A, Thurlirnann B, et al. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal wimen with endocrine'responsive early breast cancer: update of study BIG 1 -98[J]. J Clin Oncol, 2007, 25(5): 486.
